Financial News
2.5 Weeks to Deliver Desired Humanized Antibody in ProBio
500+ Antibody Humanization Projects
Guarantee no loss of affinity
The most advanced project is marketed
Antibody humanization & antibody characterization can reduce the immunogenicity of monoclonal antibodies derived from xenogeneic sources and improve their activation of the human immune system by replacing non-human antibody frameworks with human ones. It is a very important step in the therapeutic antibody discovery process. ProBio is the world’s No.1 fast antibody humanization service provider, providing 2 packages for antibody humanization services.
- 20-year experience in antibody discovery
- Delivered over 500 projects
- The most advanced project is marketed
- Guarantee no loss of affinity
- Humanization rate >95%
- Provide developability prediction reports including PTM, aggregation and immunogenicity.
- Various detection systems: SPR, ELISA, FACS
- Suitable for mAb, scFv and sdAb
Service Introduction
Express Service: As Fast as 2.5 weeks to Get Your Antibody Humanized
Through CDR grafting and back mutation technologies, the express package can be used to produce humanized antibodies with high expression levels, good thermal stability, and comparable affinity with the parental antibodies as fast as 2.5 weeks.
Deluxe Service: Get Humanized Antibody with No Affinity Loss
Deluxe package can be used to obtain the humanized antibodies without affinity loss through CDR grafting, back mutation, and FASEBA high-throughput screening technology as fast as 8 weeks.
Learn more about patented FASEBA screening platform
FASEBA is a patented E.Coli based system that selects good affinity, expression level and thermostable candidates. It is used to select the best protein binders from a large number of protein candidates in a high throughput fashion, without actually purifying these proteins.
Each saturation mutation library is transformed into FASEBA E.coli based expression system.
How to Avoid Developability Risk in the Early Stage of Discovery？
ProBio offers 3 developability assessment packages for antibody drug candidates at different discovery stages to identify the potential risks of manufacture and clinical failure.
Service Package
Deluxe Humanization --- Back mutaiton library screening with FASEBA
The turnaround time listed here is the time required for the service itself. For international shipping, please refer to the time provided by PM during project discussion.
Express plus humanization --- CDR grafting with back mutation
The turnaround time listed here is the time required for the service itself. For international shipping, please refer to the time provided by PM during project discussion.
- Human framework diversity
- Fast turnaround time
- Guaranteed delivery of humanized abs with comparable affinity with parental abs
Media Contact
Company Name: ProBio CDMOContact Person: ProBio CDMOEmail:
China: cdmo.cn@probiocdmo.com
APAC: cdmo.apac@probiocdmo.com
Europe: cdmo.eu@probiocdmo.com
Japan: cdmo.jp@probiocdmo.com
South Korea: cdmo.kr@probiocdmo.com
Phone: (+86-22) 8758-7199 ext. 6027
Website: https://www.probiocdmo.com/
Media Contact
Company Name: ProBio CDMO
Email: Send Email
Phone: +86-22 8758-7199 ext. 6027
Country: China
Website: https://www.probiocdmo.com
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
